Journal of Urology

Diseases, Conditions, Syndromes

MRI has a role to play after negative prostate biopsy

(HealthDay)—Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published in the December issue ...

Diseases, Conditions, Syndromes

PCA3 assay ups predictive accuracy for repeat biopsy

(HealthDay)—For men with at least one prior negative biopsy, urinary PCA3 scores, together with serum prostate-specific antigen and other clinical information, improve the prediction accuracy for repeat biopsy outcome, ...

Oncology & Cancer

Drop in use of digital rectal examination, PSA testing

(HealthDay)—Following U.S. Preventive Services Task Force (USPSTF) recommendations against routine prostate-specific antigen (PSA) screening, there has been a decrease in utilization of digital rectal examination and PSA ...

Diseases, Conditions, Syndromes

Growth rates of small renal masses highly variable early on

(HealthDay)—Among patients who opt for active surveillance of small renal masses, growth rates are highly variable early on and do not reliably predict adverse outcomes, according to a study published in the March issue ...

Oncology & Cancer

Metformin use does not increase prostate cancer survival

(HealthDay)—Metformin use in combination with docetaxel chemotherapy does not significantly improve survival in patients with diabetes and metastatic castration-resistant prostate cancer, according to a study published ...

Oncology & Cancer

Diagnostic factors may help patients avoid prostate biopsy

(HealthDay)—Initial diagnostic characteristics may be able to identify men initiating active surveillance who could avoid confirmatory biopsy, according to a study published in the January issue of The Journal of Urology.

page 9 from 32